Report copyright - Leukemia Committee Agenda 2003/Leukemia.pdf · Dr. Schiffer Proposed Studies S0106 A Phase III Study of the Addition of Gemtuzumab Ozogamicin (Mylotarg™) During Induction Therapy
Please pass captcha verification before submit form
Please pass captcha verification before submit form